Loading clinical trials...
Loading clinical trials...
Relative Bioavailability of a Single 200 MG Dose Of Cenobamate (YKP3089) Given As An Oral Tablet Or As An Oral Suspension And The Effect Of Food On A Single 200 MG Dose Of Cenobamate Given As An Oral Suspension
Conditions
Interventions
Cenobamate 200Mg Tab Fasted
Cenobamate Oral Suspension Fed
+1 more
Locations
1
United States
PRA Health Sciences Salt Lake City
Millcreek, Utah, United States
Start Date
December 21, 2020
Primary Completion Date
May 17, 2021
Completion Date
May 17, 2021
Last Updated
August 12, 2024
NCT00104325
NCT07388667
NCT03878121
NCT05447416
NCT01399385
NCT07090785
Lead Sponsor
SK Life Science, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions